IRIS
GROSSI, Laurino
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.206
EU - Europa 4.734
AS - Asia 4.233
SA - Sud America 473
AF - Africa 37
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 4
Totale 15.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.136
SG - Singapore 1.565
CN - Cina 1.380
UA - Ucraina 820
IT - Italia 803
IE - Irlanda 725
TR - Turchia 578
SE - Svezia 564
GB - Regno Unito 529
FR - Francia 422
BR - Brasile 383
IN - India 366
DE - Germania 314
VN - Vietnam 187
FI - Finlandia 179
RU - Federazione Russa 135
AT - Austria 64
PL - Polonia 56
AR - Argentina 32
MX - Messico 32
CA - Canada 31
NL - Olanda 27
BD - Bangladesh 23
EC - Ecuador 23
KR - Corea 21
EU - Europa 20
IQ - Iraq 19
BE - Belgio 18
RO - Romania 16
ZA - Sudafrica 16
HK - Hong Kong 15
JP - Giappone 15
ES - Italia 12
ID - Indonesia 12
LT - Lituania 11
IL - Israele 10
MA - Marocco 9
CO - Colombia 8
CL - Cile 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
GR - Grecia 6
PE - Perù 6
PK - Pakistan 6
PY - Paraguay 6
TW - Taiwan 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
KE - Kenya 4
AU - Australia 3
CH - Svizzera 3
EE - Estonia 3
IR - Iran 3
JO - Giordania 3
NO - Norvegia 3
OM - Oman 3
UY - Uruguay 3
VE - Venezuela 3
AZ - Azerbaigian 2
BO - Bolivia 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
LU - Lussemburgo 2
PA - Panama 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AP - ???statistics.table.value.countryCode.AP??? 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
PT - Portogallo 1
PW - Palau 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 15.708
Salva come PNG Salva come JPEG
Città #
Singapore 1.047
Jacksonville 943
Chandler 779
Dublin 717
Dearborn 468
Southend 378
Princeton 354
Beijing 329
Dallas 298
Nanjing 284
Izmir 272
Wilmington 254
Ashburn 247
Los Angeles 197
Cambridge 157
Woodbridge 119
Buffalo 118
Ann Arbor 115
Tongling 104
Santa Clara 101
Nanchang 93
The Dalles 93
New York 81
Boardman 66
Ho Chi Minh City 65
Houston 65
Council Bluffs 62
Hefei 56
Hebei 53
Vienna 52
Shenyang 48
Altamura 47
Munich 47
Redondo Beach 46
Rome 46
Kunming 45
Tianjin 43
Jiaxing 40
São Paulo 39
Kraków 35
Pescara 35
Chieti 29
Hanoi 28
Hangzhou 27
Bologna 25
Brooklyn 25
Norwalk 25
Dong Ket 22
Düsseldorf 20
Jinan 20
Changsha 19
Milan 19
Ancona 18
Orange 18
Warsaw 18
Brussels 17
Seoul 17
Helsinki 16
Washington 16
Bellante 15
Turku 15
Amsterdam 14
Belo Horizonte 14
Boston 14
Denver 14
Grevenbroich 14
Guangzhou 14
Hong Kong 14
Lanzhou 14
Vinh 14
Chicago 13
Nuremberg 13
Tokyo 13
Baghdad 12
Frankfurt am Main 12
Guayaquil 12
London 12
Phoenix 12
Ankara 11
Fuzhou 11
Seattle 11
Charlotte 10
Falls Church 10
Guadalajara 10
Johannesburg 10
Montreal 10
Mumbai 10
Rio de Janeiro 10
Stockholm 10
Brasília 9
Cepagatti 9
Changchun 9
San Francisco 9
Haiphong 8
Ningbo 8
Turin 8
Atlanta 7
Curitiba 7
Edinburgh 7
L'aquila 7
Totale 9.273
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 386
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 184
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 162
Ottimizzazione di vedolizumab in RCU con perdita di risposta a infliximab 149
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 144
Blood cardioplegia: could it protect the ischemic-reperfused human myocardium through antioxidant-type mechanisms? 142
24-hour pancolonic motility using a portable electronic probe in healthy subjects 142
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 142
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 140
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 140
Alterazioni non litiasiche del contenuto colecistico 135
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 134
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 130
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 129
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 129
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 127
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 126
Trasmissione di Helicobacter pylori in un modello murino 124
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 121
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 120
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 118
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 117
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 116
ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT 115
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 114
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 114
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 114
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 111
USO DI GOLIMUMAB COME SECONDA LINEA BIOLOGICA IN UN PAZIENTE CON RETTOCOLITE ULCEROSA 111
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 110
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 109
Detection of Helicobacter pylori in esophagus and saliva in humans 108
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 107
Transmission of Helicobacter pylori in an animal model. 107
REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASE (IG-IBD). 107
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 106
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 106
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 106
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 105
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 105
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 105
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 104
A “REAL LIVE” EXPERIENCE OF INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 104
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 104
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 103
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 103
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 102
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 101
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 101
Esophageal and gastric motility in patients with gastroesophageal reflux disease 100
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 100
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 99
EFFICACY AND SAFETY OF LONG-TERM INFLIXIMAB USE FOR CROHN’S DISEASE IN SOUTHERN ITALY 99
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 99
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 99
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 98
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 98
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 97
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 97
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 97
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 96
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 96
Peppermint oil (Mintoil®) in the treatment or irritable bowel syndrome: a prospective double blind placebo controlled randomized trial. 96
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 96
RISPOSTA CLINICA E GUARIGIONE DELLA MUCOSA DOPO 4 ANNI DI TERAPIA CON INFLIXIMAB IN UN PAZIENTE CON MALATTIA DI CROHN ILEALE STEROIDO-RESISTENTE 95
CLINICAL AND ECONOMIC IMPACT OF INFLIXIMAB ONE-HOUR INFUSION PROTOCOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTER STUDY 95
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 94
THERAPY-RELATED ADVERSE EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 94
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 93
Increase of swallows before the onset of phase III of migrating motor complex in normal human subjects 93
Prolonged anal sphincter manometry in normal human subjects 92
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 92
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 92
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 92
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 92
CLINICAL AND ECONOMIC EFFECT OF SHORT INFLIXIMAB INFUSION PROTOCOL IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A MULTICENTRE STUDY 92
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 91
THERAPY- RELATED ADVERS EVENTS IN CROHN’S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY 91
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 91
Registrazione delle 24 ore della motilità del piloro in soggetti normali 90
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 90
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 89
Proximal and Distal Gastric Distension in Normal Subjects and H. pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 89
LA MALDIGESTIONE 89
REAL-LIFE STUDY (GORE-UC) EVALUATING THE EFFECTIVENESS OF GOLIMUMAB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTERIM ANALYSIS FROM ITALIAN GROUP FOR THE STUDY OF INFLAMAMTORY BOWEL DISEASE (IG-IBD). 89
FPSE-HPLC-PDA METHOD FOR THE DETERMINATION OF INFLAMMATORY BOWEL DISEASE TREATMENT DRUGS IN WHOLE BLOOD, PLASMA AND URINE 89
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 88
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 88
LA MALATTIA DA REFLUSSO GASTROESOFAGEO 88
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 87
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 87
Effect of nitric oxide on propagated clusters of spontaneous motor waves in an ex vivo rabbit intestinal preparation 87
ROLE OF PRUCALOPRIDE (RESOLOR) IN THE SETTING-UP OF PILLCAM COLON-CAPSULE ENDOSCOPY (CCE). EXPERIENCEFROM A SINGLE CENTRE 87
Relationship between interdigestive esophageal and gastric motility in humans 86
Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients 86
EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN’S DISEASE 86
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 85
ON THE SPECIFICITY OF ALTERED MUSCLE FUNCTION IN EXPERIMENTAL COLITIS IN RATS 85
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 85
Role of nitric oxide on peristaltic motor activity in an in vitro rabbit intestinal preparation 85
Totale 10.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.018
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021536 0 0 0 0 0 227 18 23 30 135 21 82
2021/2022789 35 15 4 200 46 16 24 66 54 9 88 232
2022/20232.154 188 207 108 264 194 488 145 158 253 41 59 49
2023/20241.002 79 51 62 36 34 292 236 37 14 44 19 98
2024/20252.576 182 423 292 47 54 66 99 173 310 121 252 557
2025/20262.434 488 252 637 543 453 61 0 0 0 0 0 0
Totale 16.003